Understanding Tau Protein's Role in Alzheimer's Brain Connections
Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders
['FUNDING_R01'] · UNIVERSITY OF TEXAS MED BR GALVESTON · NIH-11132926
This project aims to discover how specific forms of a protein called tau harm brain connections in Alzheimer's disease and related conditions, with the goal of finding ways to protect these connections.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS MED BR GALVESTON (nih funded) |
| Locations | 1 site (GALVESTON, UNITED STATES) |
| Trial ID | NIH-11132926 on ClinicalTrials.gov |
What this research studies
Alzheimer's disease causes brain connections, known as synapses, to stop working correctly, and a protein called tau is believed to be a major factor. We are working to understand how different types of tau proteins, called conformers, specifically damage these vital connections. By studying individuals who show resilience to this damage despite having tau in their brains, we hope to uncover natural protective mechanisms. Our ultimate goal is to lay the groundwork for new treatments that can keep brain connections healthy in people affected by Alzheimer's and similar conditions.
Who could benefit from this research
Good fit: This foundational research is relevant for individuals interested in the basic biological mechanisms of Alzheimer's disease and related dementias, as it seeks to inform future treatment strategies.
Not a fit: Patients looking for immediate clinical trials or direct therapeutic interventions would not directly benefit from this early-stage, basic science project.
Why it matters
Potential benefit: If successful, this work could lead to the development of new therapies that protect brain synapses from tau protein damage, potentially slowing or preventing the progression of Alzheimer's disease.
How similar studies have performed: While the general role of tau in Alzheimer's is recognized, this specific focus on distinct tau conformers and mechanisms of synaptic resilience represents a novel and promising avenue for therapeutic discovery.
Where this research is happening
GALVESTON, UNITED STATES
- UNIVERSITY OF TEXAS MED BR GALVESTON — GALVESTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TAGLIALATELA, GIULIO — UNIVERSITY OF TEXAS MED BR GALVESTON
- Study coordinator: TAGLIALATELA, GIULIO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Alzheimer's disease and related dementia, Alzheimer's disease and related disorders